← FDA Drug Approvals (Drugs@FDA)

CETIRIZINE HYDROCHLORIDE ALLERGY

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CATALENT · Approved 2020-09-21

Drug application

FDA Application #

ANDA213105

Application type

Abbreviated New Drug Application (Generic)

Brand name

CETIRIZINE HYDROCHLORIDE ALLERGY

Generic name

CETIRIZINE HCL

Active ingredients

CETIRIZINE HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Over-the-counter

Sponsor

CATALENT

Manufacturer

WALMART INC. (see also Equate)

First approval

2020-09-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown